CNTB
Connect Biopharma Holdings Ltd
NASDAQ · Healthcare · Biotechnology · CN
$1.28
−0.78%Margins
Gross margin
100.0%
EBITDA margin
-1763.3%
EBIT margin
-1795.6%
Net margin
-1763.4%
FCF margin
-1087.1%
-192.8%
Return on equity
-119.1%
Return on assets
-192.1%
Return on invested capital
0.06x
Asset turnover
-$31.9M
Cash from operations
$0.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026